Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$1.10B
EBITDA Margin
-20.99%
TTM Avg
-14.27%
3Y Avg
-11.56%
5Y Avg
-5.13%
Market Cap
$1.10B
EBITDA Margin
-5.96%
TTM Avg
-8.24%
3Y Avg
-13.85%
5Y Avg
-8.28%
Market Cap
$1.09B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09B
EBITDA Margin
-15.54%
TTM Avg
-15.54%
3Y Avg
-2.35%
5Y Avg
5.20%
Market Cap
$1.08B
EBITDA Margin
34.04%
TTM Avg
32.58%
3Y Avg
31.87%
5Y Avg
26.02%
Market Cap
$1.08B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
EBITDA Margin
28.28%
TTM Avg
32.08%
3Y Avg
32.10%
5Y Avg
26.80%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.10B | N/A | N/A | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.10B | -20.99% | -14.27% | -11.56% | -5.13% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.10B | -5.96% | -8.24% | -13.85% | -8.28% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| STAAR Surgical Company (STAA)vs › | $1.09B | -15.54% | -15.54% | -2.35% | 5.20% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 34.04% | 32.58% | 31.87% | 26.02% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.08B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 28.28% | 32.08% | 32.10% | 26.80% |
| Nektar Therapeutics (NKTR)vs › | $1.13B | -234.91% | -168.66% | -182.22% | -232.17% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
